AlzPlatform: An Alzheimer's disease domain-specific chemogenomics knowledgebase for polypharmacology and target identification research

Journal of Chemical Information and Modeling

Volumn 54, Issue 4, 2014, Pages 1050-1060

  Liu, Haibin ^a,b   Wang, Lirong ^a   Lv, Mingliang ^b   Pei, Rongrong ^b   Li, Peibo ^b   Pei, Zhong ^b   Wang, Yonggang ^b   Su, Weiwei ^b   Xie, Xiang Qun ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

APPLICATION PROGRAMS; BIOACTIVITY; CHEMICAL ANALYSIS; DATA SHARING; DIAGNOSIS; GENES; INFORMATION DISSEMINATION; KNOWLEDGE MANAGEMENT; PROTEINS;

ALZHEIMER'S DISEASE; CHEMICAL MOLECULES; COMPUTATIONAL ALGORITHM; DOMAIN SPECIFIC; EXPERIMENTAL VALIDATIONS; INFORMATION EXCHANGES; NEURODEGENERATION; TARGET IDENTIFICATION;

NEURODEGENERATIVE DISEASES;

NEUROPROTECTIVE AGENT;

ALZHEIMER DISEASE; CHEMICAL DATABASE; DRUG DEVELOPMENT; GENETIC DATABASE; GENETICS; HEPG2 CELL LINE; HUMAN; METABOLISM;

ALZHEIMER DISEASE; DATABASES, CHEMICAL; DATABASES, GENETIC; DRUG DISCOVERY; HEP G2 CELLS; HUMANS; NEUROPROTECTIVE AGENTS;

EID: 84899849734     PISSN: 15499596     EISSN: 1549960X     Source Type: Journal    
DOI: 10.1021/ci500004h     Document Type: Article

References (82)

1. Querfurth, H. W.; LaFerla, F. M. Alzheimer's disease New Engl. J. Med. 2010, 362, 329-44
2. Wimo, A.; Winblad, B.; Jonsson, L. The worldwide societal costs of dementia: Estimates for 2009 Alzheimer's Dementia: J. Alzheimer's Assoc. 2010, 6, 98-103
3. Mattson, M. P. Pathways towards and away from Alzheimer's disease Nature 2004, 430, 631-9
4. Ray, M.; Ruan, J.; Zhang, W. Variations in the transcriptome of Alzheimer's disease reveal molecular networks involved in cardiovascular diseases Genome Biol. 2008, 9, R148
5. Dong, S.; Duan, Y.; Hu, Y.; Zhao, Z. Advances in the pathogenesis of Alzheimer's disease: a re-evaluation of amyloid cascade hypothesis Translational Neurodegeneration 2012, 1, 18
6. Bertram, L.; McQueen, M. B.; Mullin, K.; Blacker, D.; Tanzi, R. E. Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database Nat. Genet. 2007, 39, 17-23
7. Mizuno, S.; Iijima, R.; Ogishima, S.; Kikuchi, M.; Matsuoka, Y.; Ghosh, S.; Miyamoto, T.; Miyashita, A.; Kuwano, R.; Tanaka, H. AlzPathway: a comprehensive map of signaling pathways of Alzheimer's disease BMC Syst. Biol. 2012, 6, 52
8. Wang, L.; Wang, J.; Xie, Z.-J.; Ma, C.; Myint, K. Z.; Mu, Y.; Xie, X.-Q. Cloud Computing Webserver for Cannabinoid Research. In 22nd International Cannabis Research Society (ICRS) Meeting, Freiburg, Germany, July 22-27, 2012.
9. Wang, L.; Ma, C.; Wipf, P.; Liu, H.; Su, W.; Xie, X.-Q. TargetHunter: an in silico target identification tool for predicting therapeutic potential of small organic molecules based on chemogenomic database AAPS J. 2013, 15, 395-406
10. O'Boyle, N. M.; Banck, M.; James, C. A.; Morley, C.; Vandermeersch, T.; Hutchison, G. R. Open Babel: An open chemical toolbox J. Cheminf. 2011, 3, 33
11. Ertl, P. Molecular structure input on the web J. Cheminf. 2010, 2 10.1186/1758-2946-2-1
12. O'Boyle, N. M.; Banck, M.; James, C. A.; Morley, C.; Vandermeersch, T.; Hutchison, G. R. Open Babel: An open chemical toolbox J. Cheminf. 2011, 3, 1-14
13. Daynes, R. A.; Jones, D. C. Emerging roles of PPARs in inflammation and immunity Nat. Rev. Immunol. 2002, 2, 748-59
14. Trott, O.; Olson, A. J. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading J. Comput. Chem. 2010, 31, 455-461
15. Pardridge, W. M. The blood-brain barrier: bottleneck in brain drug development NeuroRx: J. Am. Soc. Exp. NeuroTherapeutics 2005, 2, 3-14
16. Vapnik, V. N. The nature of statistical learning theory; Springer: New York, 1995.
17. Xie, X. Q.; Chen, J. Z.; Billings, E. M. 3D structural model of the G-protein-coupled cannabinoid CB2 receptor Proteins 2003, 53, 307-19
18. Zhao, Y. H.; Abraham, M. H.; Ibrahim, A.; Fish, P. V.; Cole, S.; Lewis, M. L.; de Groot, M. J.; Reynolds, D. P. Predicting penetration across the blood-brain barrier from simple descriptors and fragmentation schemes J. Chem. Inf. Model 2007, 47, 170-175
19. Patlewicz, G.; Jeliazkova, N.; Safford, R. J.; Worth, A. P.; Aleksiev, B. An evaluation of the implementation of the Cramer classification scheme in the Toxtree software SAR QSAR Environ. Res. 2008, 19, 495-524
20. Baell, J. B.; Holloway, G. A. New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays J. Med. Chem. 2010, 53, 2719-40
21. Lipinski, C. A.; Lombardo, F.; Dominy, B. W.; Feeney, P. J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings Adv. Drug Delivery Rev. 2001, 46, 3-26
22. Steinbeck, C.; Han, Y.; Kuhn, S.; Horlacher, O.; Luttmann, E.; Willighagen, E. The Chemistry Development Kit (CDK): an open-source Java library for Chemo- and Bioinformatics J. Chem. Inf. Comput. Sci. 2003, 43, 493-500
23. Ewald, C. Y.; Li, C. Understanding the molecular basis of Alzheimer's disease using a Caenorhabditis elegans model system Brain Struct. Funct. 2010, 214, 263-83
24. Lewis, J. A.; Fleming, J. T. Basic culture methods. In Caenorhabditis elegans: Modern biologicalanalysis of an organism; Epstein, H. F.; Shakes, D. C., Eds.; 1995; p 4-30.
25. Sutphin, G. L.; Kaeberlein, M. Measuring Caenorhabditis elegans life span on solid media J. Vis. Exp.: JoVE 2009, 10.3791/1152
26. Lithgow, G. J.; White, T. M.; Melov, S.; Johnson, T. E. Thermotolerance and extended life-span conferred by single-gene mutations and induced by thermal stress Proc. Natl. Acad. Sci. U.S.A. 1995, 92, 7540-7544
27. Ou, Z.; Wada, T.; Gramignoli, R.; Li, S.; Strom, S. C.; Huang, M.; Xie, W. MicroRNA hsa-miR-613 targets the human LXRalpha gene and mediates a feedback loop of LXRalpha autoregulation Mol. Endocrinol. 2011, 25, 584-96
28. Heinrich, J. N.; Butera, J. A.; Carrick, T.; Kramer, A.; Kowal, D.; Lock, T.; Marquis, K. L.; Pausch, M. H.; Popiolek, M.; Sun, S. C.; Tseng, E.; Uveges, A. J.; Mayer, S. C. Pharmacological comparison of muscarinic ligands: historical versus more recent muscarinic M1-preferring receptor agonists Eur. J. Pharmacol. 2009, 605, 53-6
29. Klaver, D. W.; Wilce, M. C.; Cui, H.; Hung, A. C.; Gasperini, R.; Foa, L.; Small, D. H. Is BACE1 a suitable therapeutic target for the treatment of Alzheimer's disease? Current strategies and future directions Biol. Chem. 2010, 391, 849-59
30. Evin, G.; Hince, C. BACE1 as a therapeutic target in Alzheimer's disease: rationale and current status Drugs Aging 2013, 30, 755-64
31. Cai, Z.; Ratka, A. Opioid system and Alzheimer's disease Neuromol. Med. 2012, 14, 91-111
32. Ramírez, B. G.; Blázquez, C.; del Pulgar, T. G.; Guzmán, M.; de Ceballos, M. L. Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation J. Neurosci. 2005, 25, 1904-1913
33. Liu, H.; Liang, F.; Su, W.; Wang, N.; Lv, M.; Li, P.; Pei, Z.; Zhang, Y.; Xie, X. Q.; Wang, L.; Wang, Y. Lifespan extension by n-butanol extract from seed of Platycladus orientalis in Caenorhabditis elegans J. Ethnopharmacol. 2013, 147, 366-72
34. Ambrosio, A. L.; Dias, S. M.; Polikarpov, I.; Zurier, R. B.; Burstein, S. H.; Garratt, R. C. Ajulemic acid, a synthetic nonpsychoactive cannabinoid acid, bound to the ligand binding domain of the human peroxisome proliferator- activated receptor gamma J. Biol. Chem. 2007, 282, 18625-33
35. Lee, J. H.; Gong, H.; Khadem, S.; Lu, Y.; Gao, X.; Li, S.; Zhang, J.; Xie, W. Androgen deprivation by activating the liver X receptor Endocrinol. 2008, 149, 3778-88
36. Sastre, M.; Dewachter, I.; Landreth, G. E.; Willson, T. M.; Klockgether, T.; van Leuven, F.; Heneka, M. T. Nonsteroidal anti-inflammatory drugs and peroxisome proliferator-activated receptor-gamma agonists modulate immunostimulated processing of amyloid precursor protein through regulation of beta-secretase J. Neurosci.: Off. J. Soc. Neurosci. 2003, 23, 9796-804
37. Heneka, M. T.; Sastre, M.; Dumitrescu-Ozimek, L.; Hanke, A.; Dewachter, I.; Kuiperi, C.; O'Banion, K.; Klockgether, T.; Van Leuven, F.; Landreth, G. E. Acute treatment with the PPARgamma agonist pioglitazone and ibuprofen reduces glial inflammation and Abeta1-42 levels in APPV717I transgenic mice Brain: J. Neurol. 2005, 128, 1442-53
38. Sastre, M.; Dewachter, I.; Rossner, S.; Bogdanovic, N.; Rosen, E.; Borghgraef, P.; Evert, B. O.; Dumitrescu-Ozimek, L.; Thal, D. R.; Landreth, G.; Walter, J.; Klockgether, T.; van Leuven, F.; Heneka, M. T. Nonsteroidal anti-inflammatory drugs repress beta-secretase gene promoter activity by the activation of PPARgamma Proc. Natl. Acad. Sci. U.S.A. 2006, 103, 443-8
39. Cunard, R.; Ricote, M.; DiCampli, D.; Archer, D. C.; Kahn, D. A.; Glass, C. K.; Kelly, C. J. Regulation of cytokine expression by ligands of peroxisome proliferator activated receptors J. Immunol. 2002, 168, 2795-802
40. Kurisu, M.; Miyamae, Y.; Murakami, K.; Han, J.; Isoda, H.; Irie, K.; Shigemori, H. Inhibition of amyloid beta aggregation by acteoside, a phenylethanoid glycoside Biosci., Biotechnol., Biochem. 2013, 77, 1329-32
41. Wang, H.; Xu, Y.; Yan, J.; Zhao, X.; Sun, X.; Zhang, Y.; Guo, J.; Zhu, C. Acteoside protects human neuroblastoma SH-SY5Y cells against beta-amyloid-induced cell injury Brain Res. 2009, 1283, 139-47
42. Yan, S. D.; Fu, J.; Soto, C.; Chen, X.; Zhu, H.; Al-Mohanna, F.; Collison, K.; Zhu, A.; Stern, E.; Saido, T.; Tohyama, M.; Ogawa, S.; Roher, A.; Stern, D. An intracellular protein that binds amyloid-beta peptide and mediates neurotoxicity in Alzheimer's disease Nature 1997, 389, 689-95
43. Yan, S. D.; Shi, Y.; Zhu, A.; Fu, J.; Zhu, H.; Zhu, Y.; Gibson, L.; Stern, E.; Collison, K.; Al-Mohanna, F.; Ogawa, S.; Roher, A.; Clarke, S. G.; Stern, D. M. Role of ERAB/L-3-hydroxyacyl-coenzyme A dehydrogenase type II activity in Abeta-induced cytotoxicity J. Biol. Chem. 1999, 274, 2145-56
44. Samy, A. S.; Igwe, O. J. Regulation of IL-1beta-induced cyclooxygenase-2 expression by interactions of Abeta peptide, apolipoprotein E and nitric oxide in human neuroglioma J. Mol. Neurosci.: MN 2012, 47, 533-45
45. Keiser, M. J.; Setola, V.; Irwin, J. J.; Laggner, C.; Abbas, A. I.; Hufeisen, S. J.; Jensen, N. H.; Kuijer, M. B.; Matos, R. C.; Tran, T. B.; Whaley, R.; Glennon, R. A.; Hert, J.; Thomas, K. L.; Edwards, D. D.; Shoichet, B. K.; Roth, B. L. Predicting new molecular targets for known drugs Nature 2009, 462, 175-81
46. Pohanka, M. Cholinesterases, a target of pharmacology and toxicology Biomed. Pap. Med. Faculty Univ. Palacky, Olomouc, Czechoslovakia 2011, 155, 219-29
47. Li, Q.; Wu, D.; Zhang, L.; Zhang, Y. Effects of galantamine on beta-amyloid release and beta-site cleaving enzyme 1 expression in differentiated human neuroblastoma SH-SY5Y cells Exp. Gerontol. 2010, 45, 842-7
48. Mohamed, T.; Yeung, J. C.; Vasefi, M. S.; Beazely, M. A.; Rao, P. P. Development and evaluation of multifunctional agents for potential treatment of Alzheimer's disease: application to a pyrimidine-2,4-diamine template Bioorg. Med. Chem. Lett. 2012, 22, 4707-12
49. Kamat, P. K.; Tota, S.; Rai, S.; Swarnkar, S.; Shukla, R.; Nath, C. A study on neuroinflammatory marker in brain areas of okadaic acid (ICV) induced memory impaired rats Life Sci. 2012, 90, 713-20
50. Song, X. Y.; Hu, J. F.; Chu, S. F.; Zhang, Z.; Xu, S.; Yuan, Y. H.; Han, N.; Liu, Y.; Niu, F.; He, X.; Chen, N. H. Ginsenoside Rg1 attenuates okadaic acid induced spatial memory impairment by the GSK3beta/tau signaling pathway and the Abeta formation prevention in rats Eur. J. Pharmacol. 2013, 710, 29-38
51. Onogi, H.; Ishigaki, S.; Nakagawasai, O.; Arai-Kato, Y.; Arai, Y.; Watanabe, H.; Miyamoto, A.; Tan-no, K.; Tadano, T. Influence of memantine on brain monoaminergic neurotransmission parameters in mice: neurochemical and behavioral study Biol. Pharmaceut. Bull. 2009, 32, 850-5
52. Marvanova, M.; Wong, G. Adenosine A2A receptor mRNA expression is increased in rat striatum and nucleus accumbens after memantine administration Brain Res. Mol. Brain Res. 2004, 120, 193-6
53. Rai, S.; Kamat, P. K.; Nath, C.; Shukla, R. A study on neuroinflammation and NMDA receptor function in STZ (ICV) induced memory impaired rats J. Neuroimmunol. 2013, 254, 1-9
54. Wegner, F.; Kraft, R.; Busse, K.; Schaarschmidt, G.; Hartig, W.; Schwarz, S. C.; Schwarz, J. Glutamate receptor properties of human mesencephalic neural progenitor cells: NMDA enhances dopaminergic neurogenesis in vitro J. Neurochem. 2009, 111, 204-16
55. Goni-Oliver, P.; Avila, J.; Hernandez, F. Memantine inhibits calpain-mediated truncation of GSK-3 induced by NMDA: implications in Alzheimer's disease J. Alzheimer's Disease: JAD 2009, 18, 843-8
56. Nordberg, A. Mechanisms behind the neuroprotective actions of cholinesterase inhibitors in Alzheimer disease Alzheimer Disease Assoc. Disorders 2006, 20, S12-8
57. Wu, H. M.; Tzeng, N. S.; Qian, L.; Wei, S. J.; Hu, X.; Chen, S. H.; Rawls, S. M.; Flood, P.; Hong, J. S.; Lu, R. B. Novel neuroprotective mechanisms of memantine: increase in neurotrophic factor release from astroglia and anti-inflammation by preventing microglial activation Neuropsychopharmacol.: Off. Publication Am. College Neuropsychopharmacol. 2009, 34, 2344-57
58. Kano, O.; Ito, H.; Takazawa, T.; Kawase, Y.; Murata, K.; Iwamoto, K.; Nagaoka, T.; Hirayama, T.; Miura, K.; Nagata, R.; Kiyozuka, T.; Aoyagi, J.; Sato, R.; Eguchi, T.; Ikeda, K.; Iwasaki, Y. Clinically meaningful treatment responses after switching to galantamine and with addition of memantine in patients with Alzheimer's disease receiving donepezil Neuropsychiatric Disease Treatment 2013, 9, 259-65
59. Wang, L.; Xiong, Y.; Sun, Y.; Fang, Z.; Li, L.; Ji, H.; Shi, T. HLungDB: an integrated database of human lung cancer research Nucleic Acids Res. 2010, 38, D665-D669
60. Gu, J.; Gui, Y.; Chen, L.; Yuan, G.; Xu, X. CVDHD: a cardiovascular disease herbal database for drug discovery and network pharmacology J. Cheminf. 2013, 5, 1-6
61. Irwin, J. J.; Shoichet, B. K.; Mysinger, M. M.; Huang, N.; Colizzi, F.; Wassam, P.; Cao, Y. Automated docking screens: a feasibility study J. Med. Chem. 2009, 52, 5712-5720
62. Xie, X.-Q.; Wang, L.; Liu, H.; Ouyang, Q.; Fang, C.; Su, W., Chemogenomics Knowledgebased Polypharmacology Analyses of Drug Abuse Related G-Protein Coupled Receptors and Their Ligands. Frontiers Pharmacol. 2014, 5.
63. Hopkins, A. L. Network pharmacology: the next paradigm in drug discovery Nat. Chem. Biol. 2008, 4, 682-90
64. Bolognesi, M. L.; Matera, R.; Minarini, A.; Rosini, M.; Melchiorre, C. Alzheimer's disease: new approaches to drug discovery Curr. Opin. Chem. Biol. 2009, 13, 303-8
65. Ouyang, Q.; Tong, Q.; Feng, R.; Myint, K.-Z.; Yang, P.; Xie, X.-Q. Trisubstituted Sulfonamides: A New Chemotype for Development of Potent and Selective CB2 Receptor Inverse Agonists ACS Med. Chem. Lett. 2013, 4, 387-392
66. Hamulakova, S.; Janovec, L.; Hrabinova, M.; Kristian, P.; Kuca, K.; Banasova, M.; Imrich, J. Synthesis, design and biological evaluation of novel highly potent tacrine congeners for the treatment of Alzheimer's disease Eur. J. Med. Chem. 2012, 55, 23-31
67. Peng, D. Y.; Sun, Q.; Zhu, X. L.; Lin, H. Y.; Chen, Q.; Yu, N. X.; Yang, W. C.; Yang, G. F. Design, synthesis, and bioevaluation of benzamides: novel acetylcholinesterase inhibitors with multi-functions on butylcholinesterase, Abeta aggregation, and beta-secretase Bioorg. Med. Chem. 2012, 20, 6739-6750
68. Sterling, J.; Herzig, Y.; Goren, T.; Finkelstein, N.; Lerner, D.; Goldenberg, W.; Miskolczi, I.; Molnar, S.; Rantal, F.; Tamas, T.; Toth, G.; Zagyva, A.; Zekany, A.; Finberg, J.; Lavian, G.; Gross, A.; Friedman, R.; Razin, M.; Huang, W.; Krais, B.; Chorev, M.; Youdim, M. B.; Weinstock, M. Novel dual inhibitors of AChE and MAO derived from hydroxy aminoindan and phenethylamine as potential treatment for Alzheimer's disease J. Med. Chem. 2002, 45, 5260-5279
69. Bolognesi, M. L.; Banzi, R.; Bartolini, M.; Cavalli, A.; Tarozzi, A.; Andrisano, V.; Minarini, A.; Rosini, M.; Tumiatti, V.; Bergamini, C.; Fato, R.; Lenaz, G.; Hrelia, P.; Cattaneo, A.; Recanatini, M.; Melchiorre, C. Novel class of quinone-bearing polyamines as multi-target-directed ligands to combat Alzheimer's disease J. Med. Chem. 2007, 50, 4882-4897
70. Williams, M.; Kowaluk, E. A.; Arneric, S. P. Emerging molecular approaches to pain therapy J. Med. Chem. 1999, 42, 1481-1500
71. Kroemer, R. T.; Koutsilieri, E.; Hecht, P.; Liedl, K. R.; Riederer, P.; Kornhuber, J. Quantitative analysis of the structural requirements for blockade of the N-methyl-D-aspartate receptor at the phencyclidine binding site J. Med. Chem. 1998, 41, 393-400
72. Banerjee, A.; Schepmann, D.; Kohler, J.; Wurthwein, E. U.; Wunsch, B. Synthesis and SAR studies of chiral non-racemic dexoxadrol analogues as uncompetitive NMDA receptor antagonists Bioorg. Med. Chem. 2010, 18, 7855-7867
73. Takayama, H.; Yaegashi, Y.; Kitajima, M.; Han, X.; Nishimura, K.; Okuyama, S.; Igarashi, K. Design, synthesis, and biological evaluation of tricyclic heterocycle-tetraamine conjugates as potent NMDA channel blockers Bioorg. Med. Chem. Lett. 2007, 17, 4729-4732
74. Li, Q.; Wu, D.; Zhang, L.; Zhang, Y. Effects of galantamine on beta-amyloid release and beta-site cleaving enzyme 1 expression in differentiated human neuroblastoma SH-SY5Y cells Exp. Gerontol. 2010, 45, 842-847
75. Mohamed, T.; Yeung, J. C.; Vasefi, M. S.; Beazely, M. A.; Rao, P. P. Development and evaluation of multifunctional agents for potential treatment of Alzheimer's disease: application to a pyrimidine-2,4-diamine template Bioorg. Med. Chem. Lett. 2012, 22, 4707-4712
76. Kamat, P. K.; Tota, S.; Rai, S.; Swarnkar, S.; Shukla, R.; Nath, C. A study on neuroinflammatory marker in brain areas of okadaic acid (ICV) induced memory impaired rats Life Sci. 2012, 90, 713-720
77. Song, X. Y.; Hu, J. F.; Chu, S. F.; Zhang, Z.; Xu, S.; Yuan, Y. H.; Han, N.; Liu, Y.; Niu, F.; He, X.; Chen, N. H. Ginsenoside Rg1 attenuates okadaic acid induced spatial memory impairment by the GSK3beta/tau signaling pathway and the Abeta formation prevention in rats Eur. J. Pharmacol. 2013, 710, 29-38
78. Onogi, H.; Ishigaki, S.; Nakagawasai, O.; Arai-Kato, Y.; Arai, Y.; Watanabe, H.; Miyamoto, A.; Tan-no, K.; Tadano, T. Influence of memantine on brain monoaminergic neurotransmission parameters in mice: neurochemical and behavioral study Biol. Pharma. Bull. 2009, 32, 850-855
79. Marvanova, M.; Wong, G. Adenosine A2A receptor mRNA expression is increased in rat striatum and nucleus accumbens after memantine administration Brain Res. Mol. Brain Res. 2004, 120, 193-196
80. Rai, S.; Kamat, P. K.; Nath, C.; Shukla, R. A study on neuroinflammation and NMDA receptor function in STZ (ICV) induced memory impaired rats J. Neuroimmun. 2013, 254, 1-9
81. Wegner, F.; Kraft, R.; Busse, K.; Schaarschmidt, G.; Hartig, W.; Schwarz, S. C.; Schwarz, J. Glutamate receptor properties of human mesencephalic neural progenitor cells: NMDA enhances dopaminergic neurogenesis in vitro J. Neurochem. 2009, 111, 204-216
82. Goni-Oliver, P.; Avila, J.; Hernandez, F. Memantine inhibits calpain-mediated truncation of GSK-3 induced by NMDA: implications in Alzheimer's disease J. Alzheimer's Dis.: JAD 2009, 18, 843-848